EG-018
EG-018 is a synthetic cannabinoid, similar in structure with Naphthalen-1-yl-(1-pentylindol-3-yl)methanone, known also as JWH-018. It acts as a full agonist with a binding affinity of 5.4nM at CB1 and 0.28nM at CB2 cannabinoid receptors.
Chemistry[edit | edit source]
EG-018 is a carbazole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor. It has a similar structure to JWH-018. The formal name for EG-018 is naphthalen-1-yl(9-pentyl-9H-carbazol-3-yl)methanone.
Pharmacology[edit | edit source]
EG-018 is a full agonist at both the CB1 and CB2 cannabinoid receptors, with a reported binding affinity of 5.4nM at CB1 and 0.28nM at CB2. It is an analog of JWH-018, which means it has similar effects.
Legality[edit | edit source]
The legality of EG-018 varies from country to country. In the United States, it is a Schedule I controlled substance. In the United Kingdom, it is a Class B drug under the Misuse of Drugs Act 1971.
See also[edit | edit source]
References[edit | edit source]
EG-018 Resources | ||
---|---|---|
|
|
|
Find a healthcare provider anywhere in the world quickly and easily!
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
WikiMD is the world's largest, free medical and wellness encyclopedia edited only by professionals. Advertise!
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD